节点文献
肿瘤坏死因子拮抗剂在治疗回纹型风湿症中的临床应用价值
Clinical value of tumor necrosis factor antagonists in treatment of palindromic rheumatism
【摘要】 回纹型风湿症(PR)是一种病因不明的罕见病,其发病机制尚不明确,治疗手段有限,基本属于经验性治疗,缺乏公认的特效治疗方法和疗效评价标准。TNF-α在PR免疫微环境中扮演重要角色,参与调控PR炎症反应,因此TNF-α可能是PR的有效治疗靶点。本文通过回顾相关文献及总结临床治疗经验,阐述PR的诊断要点与发病机制,并探讨肿瘤坏死因子拮抗剂治疗PR的临床应用价值。
【Abstract】 Cause of palindromic rheumatism(PR), an uncommon condition, is unknown. There are currently few available treatments, and its pathophysiology is yet unknown. It lacks established precise treatment methods and standards for evaluating efficacy, making it essentially an empirical treatment. TNF-α contributes to regulation of PR’s inflammatory response and is crucial to immunological milieu of PR. Consequently, TNF-α can be a useful therapeutic target for PR. This paper addresses diagnosis and pathophysiology of PR, analyzes pertinent research, summarizes clinical treatment experience, and investigates potential clinical utility of tumor necrosis factor antagonists in management of PR.
【Key words】 Tumor necrosis factor antagonists; Palindromic rheumatism; Clinical value;
- 【文献出处】 中国免疫学杂志 ,Chinese Journal of Immunology , 编辑部邮箱 ,2026年02期
- 【分类号】R593.2
- 【下载频次】25